Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics

Research performed in South African (SA) breast, ovarian and prostate cancer patients resulted in the development of a rapid BRCA point-of-care (POC) assay designed as a time- and cost-effective alternative to laboratory-based technologies currently used for first-tier germline DNA testing. In this...

Full description

Bibliographic Details
Main Authors: Lwando Mampunye, Nerina C. van der Merwe, Kathleen A. Grant, Armand V. Peeters, Rispah Torrorey-Sawe, David J. French, Kelebogile E. Moremi, Martin Kidd, Petrus C. van Eeden, Fredrieka M. Pienaar, Maritha J. Kotze
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.619817/full